ENPP1 POLYPEPTIDES AND METHODS OF USING SAME

Abstract: the present disclosure includes enpp1 mutant polypeptides with improved in vivo half-lives.

Inventor(s): Paul Stabach, Demetrios Braddock

CPC Classification: C12N9/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media ))

Search for rejections for patent application number 20250230423